Dernières nouvelles

Information non disponible

11 enregistrements « 1 de 2 »

Brillant-Marquis F, Proulx É, Ratnarajah K, Lavoie A, Gauthier A, Gagnon R, Boursiquot JN, Verreault N, Marois L, Bédard MA, Boivin M, Bédard PM, Ouakki M, De Serres G, Drolet JP

Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults

Article de revue

J Allergy Clin Immunol Pract, 12 (2), 2024.

Résumé | Liens:

Simard ML, Novak N, Drolet JP, Joly MC, Nolte H, Wuestenberg E, Gagnon R

Tolerability of sublingual versus vestibular allergy immunotherapy tablet administration: A randomized pilot study

Article de revue

Clin Exp Allergy, 54 (2), 2024.

Résumé | Liens:

Picard M, Drolet JP, Masse MS, Filion CA, ALMuhizi F, Fein M, Copaescu A, Isabwe GAC, Blaquière M, Primeau MN

Safety of COVID-19 vaccination in patients with polyethylene glycol allergy: A case series

Article de revue

J Allergy Clin Immunol Pract, 10 (2), 2022.

| Liens:

Zafack JG, Toth E, Landry M, Drolet JP, Top KA, De Serres G

Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance In Quebec, Canada

Article de revue

Pediatr Infect Dis J, 38 (4), 2019.

Résumé | Liens:

Desjardins M, Béland M, Dembele M, Lejtenyi D, Drolet JP, Lemire M, Tsoukas C, Ben-Shoshan M, Noya FJD, Alizadehfar R, McCusker CT, Mazer BD

Modulation of the Interleukin-21 Pathway with Interleukin-4 Distinguishes Common Variable Immunodeficiency Patients with More Non-infectious Clinical Complications

Article de revue

J Clin Immunol, 38 (1), 2018.

Résumé | Liens:

Zafack JG, De Serres G, Rouleau I, Gariepy MC, Gagnon R, Drolet JP, Skowronski DM

Clinical Approach Used in Medical Consultations for Allergic-Like Events Following Immunization: Case Series Report in Relation to Practice Guidelines

Article de revue

J Allergy Clin Immunol Pract, 5 (3), 2017.

Résumé | Liens:

Viel-Theriault I, Thibeault R, Boucher FD, Drolet JP

Thalidomide in Refractory Tuberculomas and Pseudoabscesses

Article de revue

Pediatr Infect Dis J, 35 (11), 2016.

Résumé | Liens:

Rouleau I, De Serres G, Skowronski DM, Drolet JP, Lemire C, Toth E, Landry M

Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada

Article de revue

Vaccine, 32 (28), 2014.

Résumé | Liens:

Rouleau I, De Serres G, Drolet JP, Skowronski D, Ouakki M, Toth E, Landry M, Menard S, Gagnon R

Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine

Article de revue

Vaccine, 31 (50), 2013.

Résumé | Liens:

Rouleau I, De Serres G, Drolet JP, Banerjee D, Lemire C, Moore A, Paradis L, Alizadhefar R, Des Roches A, Chan ES, Stark D, Benoit M, Skowronski DM,

Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE

Article de revue

J Allergy Clin Immunol, 130 (6), 2012.

| Liens:

11 enregistrements « 1 de 2 »
Signaler des ajouts ou des modifications